BRCA1 and posterior cortical atrophy: In one of the few available Turkish series, Manguoğlu et al. reported germline BRCA1/2 mutations in high-risk patients with breast, ovarian, and PCa, highlighting the genetic heterogeneity of this population and the need for more comprehensive, PCa-focused genomic profiling [8].